SinuSonic

Executive Summary

SinuSonic is a San Francisco-based medical device company focused on non-invasive, drug-free solutions for nasal congestion. Founded in 2018, the company has developed a novel device that uses acoustic vibration and positive expiratory pressure (PEP) to naturally open nasal passages and improve sinus drainage. This technology addresses a large and underserved market of chronic sinusitis and allergy sufferers who seek alternatives to medications or invasive procedures. SinuSonic's device is portable, reusable, and designed for at-home use, offering a unique value proposition in the respiratory device space. The company has not disclosed funding or revenue details, but its presence in the competitive medical device landscape suggests early traction.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation device70% success
• Q4 2026Strategic partnership with national pharmacy chain for retail distribution50% success
• Q2 2026Publication of clinical trial data in peer-reviewed journal80% success